Evidence map›Paper›PMID 19597576›Full record

ReviewMarine drugs2009

Advances in marine microbial symbionts in the china sea and related pharmaceutical metabolites.

Zhiyong Li

Open access · goldAbstract readReview
In one paragraph

Review in Marine drugs, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 75 citations in OpenAlex.

  1. Review
  2. Anticancer Effect of Mycotoxins FromInternational journal of microbiology · 2024
    Review
  3. Comparative genomic characterization ofFrontiers in microbiology · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Microbial natural products: molecular blueprints for antitumor drugs.Journal of industrial microbiology & biotechnology · 2013
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Zhiyong LiLaboratory of Marine Biotechnology, School of Life Sciences and Biotechnology and Key Laboratory of Microbial Metabolism, Ministry of Education, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, P.R. China. zyli@sjtu.edu.cn
Shanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Marine animals and plants such as sponges, sea squirts, corals, worms and algae host diverse and abundant symbiotic microorganisms. Marine microbial symbionts are possible the true producers or take part in the biosynthesis of some bioactive marine natural products isolated from the marine organism hosts. Investigation of the pharmaceutical metabolites may reveal the biosynthesis mechanisms of related natural products and solve the current problem of supply limitation in marine drug development. This paper reviews the advances in diversity revelation, biological activity and related pharmaceutical metabolites, and functional genes of marine microbial symbionts from the China Sea.

Indexed as

Bacterial Physiological PhenomenaAnimalsBacteriaBiological ProductsFungiInvertebratesMarine BiologyOceans and SeasPharmaceutical PreparationsSymbiosisBiological ProductsPharmaceutical Preparationsbiological activitydiversitygeneMarine microbial symbiontsnatural products

Identifiers

PMID19597576
PMCPMC2707038
OpenAlexW2158720583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.